Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Ahmadzay ZF, Heberg J, Jørgensen JB, Ørnbjerg LM, Østergaard M, Møller-Bisgaard S, Michelsen B, Loft AG, Jones GT, Hellamand P, Scherer A, Nissen MJ, Pavelka K, Závada J, Laas K, Vorobjov S, Nordström D, Sokka-Isler T, Regierer AC, Reich A, Gudbjornsson B, Thorarinsdottir K, Iannone F, Favalli EG, van de Sande M, Provan SA, Kvien TK, Rodrigues AM, Gonçalves CF, Codreanu C, Mogosan C, Rotar Z, Prikmajer KP, Castrejon I, Otero-Varela L, Di Giuseppe D, Wallman JK, Ciurea A, Möller B, Kenar-Artın G, Yıldırım TD, Macfarlane GJ, Rotariu O, Glintborg B, Hetland ML. Ahmadzay ZF, et al. Among authors: zavada j. Rheumatol Adv Pract. 2024 Nov 5;8(4):rkae135. doi: 10.1093/rap/rkae135. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39611201 Free PMC article.
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Pons M, Georgiadis S, Østergaard M, Ahmadzay ZF, Glintborg B, Heberg J, Christensen SN, Rasmussen S, Loft AG, Castrejón I, Sánchez-Alonso F, Iannone F, Nordström D, Hokkanen AM, Ciurea A, Nissen MJ, Závada J, Pavelka K, Rotar Z, Pirkmajer KP, Michelsen B, Mielnik P, Bernardes M, Khmelinskii N, Laas K, Vorobjov S, Codreanu C, Macfarlane GJ, Jones GT, Gudbjornsson B, Palsson O, Wallman JK, Horst-Bruinsma IV, Onen F, Hetland ML, Ørnbjerg LM. Pons M, et al. Among authors: zavada j. Joint Bone Spine. 2024 Nov 26:105824. doi: 10.1016/j.jbspin.2024.105824. Online ahead of print. Joint Bone Spine. 2024. PMID: 39608666 Free article.
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries.
Ørnbjerg LM, Georgiadis S, Kvien TK, Michelsen B, Rasmussen S, Pavelka K, Zavada J, Loft AG, Kenar G, Solmaz D, Glintborg B, Rodrigues A, Santos MJ, Di Guiseppe D, Wallman JK, Ciurea A, Nissen MJ, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Gudbjornsson B, Palsson O, Hetland ML, Østergaard M. Ørnbjerg LM, et al. Among authors: zavada j. RMD Open. 2024 Nov 2;10(4):e004644. doi: 10.1136/rmdopen-2024-004644. RMD Open. 2024. PMID: 39489531 Free PMC article.
Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry.
Tichý Š, Nekvindová L, Baranová J, Vencovský J, Pavelka K, Horák P, Závada J. Tichý Š, et al. Among authors: zavada j. Scand J Rheumatol. 2024 Aug 6:1-8. doi: 10.1080/03009742.2024.2381746. Online ahead of print. Scand J Rheumatol. 2024. PMID: 39105330
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Christiansen SN, Horskjær Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, Codreanu C, Ciurea A, Glintborg B, Santos MJ, Sari I, Rotar Z, Gudbjornsson B, Macfarlane GJ, Relas H, Iannone F, Laas K, Wallman JK, van de Sande M, Provan SA, Castrejon I, Zavada J, Mogosan C, Nissen MJ, Loft AG, Barcelos A, Erez Y, Pirkmajer KP, Grondal G, Jones GT, Hokkanen AM, Chimenti MS, Vorobjov S, Di Giuseppe D, Kvien TK, Otero-Varela L, van der Horst-Bruinsma I, Hetland ML, Ørnbjerg LM. Christiansen SN, et al. Among authors: zavada j. RMD Open. 2024 Jul 24;10(3):e004166. doi: 10.1136/rmdopen-2024-004166. RMD Open. 2024. PMID: 39053949 Free PMC article.
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Hellamand P, van de Sande MGH, Nurmohamed MT, van Vollenhoven RF, Hollick RJ, Rotariu O, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Michelsen B, Kvien TK, Glintborg B, Hetland ML, Østergaard M, Loft AG, Pavelka K, Zavada J, Castrejon I, Otero-Varela L, Gudbjornsson B, Palsson O, Olofsson T, Wallman JK, Ciurea A, Nissen MJ, Yildirim TD, Onen F, Codreanu C, Mogosan C, Santos MJ, Vieira-Sousa E, Iannone F, Frediani B, Ørnbjerg LM, Twisk JWR, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: zavada j. Rheumatology (Oxford). 2024 Jul 23:keae370. doi: 10.1093/rheumatology/keae370. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39041780
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Linde L, Georgiadis S, Ørnbjerg LM, Rasmussen SH, Michelsen B, Askling J, Di Giuseppe D, Wallman JK, Závada J, Pavelka K, Bernardes M, Matos CO, Glintborg B, Loft AG, Nordström D, Kuusalo L, Möller B, Nissen MJ, Codreanu C, Mogosan C, Gudbjornsson B, Love TJ, Akleylek C, Iannone F, Kvien TK, Rotar Z, Castrejon I, Macfarlane GJ, Hetland ML, Østergaard M. Linde L, et al. Among authors: zavada j. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1558-1565. doi: 10.1002/acr.25396. Epub 2024 Aug 19. Arthritis Care Res (Hoboken). 2024. PMID: 38926900
171 results